Paramount Bed Holdings Co., Ltd.
Paramount Bed Holdings Co., Ltd. 7817.T Peers
See (7817.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 7817.T | $2,474.00 | +4.61% | 138.71B | 18.85 | $131.26 | +3.92% |
| 7741.T | $18,005.00 | +0.36% | 6.12T | 30.32 | $593.81 | +0.89% |
| 4543.T | $2,677.50 | -1.80% | 3.95T | 31.78 | $84.25 | +0.97% |
| 7733.T | $1,904.00 | -1.68% | 2.15T | 18.52 | $102.83 | +1.05% |
| 6869.T | $2,467.00 | -6.45% | 1.54T | 28.70 | $85.97 | +1.22% |
| 7747.T | $2,195.00 | +0.02% | 596.22B | 32.69 | $67.15 | +0.93% |
| 8086.T | $1,306.00 | +0.15% | 213.00B | 47.01 | $27.78 | +1.91% |
| 3046.T | $8,610.00 | -0.12% | 200.96B | 29.73 | $289.63 | +1.06% |
| 3360.T | $1,807.00 | -3.29% | 170.49B | 11.27 | $160.32 | +3.21% |
| 7716.T | $1,841.00 | -0.65% | 154.44B | 27.60 | $66.71 | +2.82% |
Stock Comparison
7817.T vs 7741.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7741.T has a market cap of 6.12T. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7741.T trades at $18,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7741.T's P/E ratio is 30.32. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7741.T's ROE of +0.20%. Regarding short-term risk, 7817.T is more volatile compared to 7741.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 4543.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 4543.T has a market cap of 3.95T. Regarding current trading prices, 7817.T is priced at $2,474.00, while 4543.T trades at $2,677.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 4543.T's P/E ratio is 31.78. In terms of profitability, 7817.T's ROE is +0.07%, compared to 4543.T's ROE of +0.09%. Regarding short-term risk, 7817.T is more volatile compared to 4543.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7733.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7733.T has a market cap of 2.15T. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7733.T trades at $1,904.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7733.T's P/E ratio is 18.52. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7733.T's ROE of +0.11%. Regarding short-term risk, 7817.T is more volatile compared to 7733.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 6869.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 6869.T has a market cap of 1.54T. Regarding current trading prices, 7817.T is priced at $2,474.00, while 6869.T trades at $2,467.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 6869.T's P/E ratio is 28.70. In terms of profitability, 7817.T's ROE is +0.07%, compared to 6869.T's ROE of +0.13%. Regarding short-term risk, 7817.T is less volatile compared to 6869.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7747.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7747.T has a market cap of 596.22B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7747.T trades at $2,195.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7747.T's P/E ratio is 32.69. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7747.T's ROE of +0.12%. Regarding short-term risk, 7817.T is more volatile compared to 7747.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 8086.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 8086.T has a market cap of 213.00B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 8086.T trades at $1,306.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 8086.T's P/E ratio is 47.01. In terms of profitability, 7817.T's ROE is +0.07%, compared to 8086.T's ROE of +0.02%. Regarding short-term risk, 7817.T is more volatile compared to 8086.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 3046.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 3046.T has a market cap of 200.96B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 3046.T trades at $8,610.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 3046.T's P/E ratio is 29.73. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3046.T's ROE of +0.27%. Regarding short-term risk, 7817.T is more volatile compared to 3046.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 3360.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 3360.T has a market cap of 170.49B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 3360.T trades at $1,807.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 3360.T's P/E ratio is 11.27. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3360.T's ROE of +0.12%. Regarding short-term risk, 7817.T is more volatile compared to 3360.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7716.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7716.T has a market cap of 154.44B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7716.T trades at $1,841.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7716.T's P/E ratio is 27.60. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7716.T's ROE of +0.07%. Regarding short-term risk, 7817.T is more volatile compared to 7716.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7730.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7730.T has a market cap of 118.06B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7730.T trades at $1,198.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7730.T's P/E ratio is 19.58. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7730.T's ROE of +0.11%. Regarding short-term risk, 7817.T is more volatile compared to 7730.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7780.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7780.T has a market cap of 86.71B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7780.T trades at $1,142.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7780.T's P/E ratio is 18.51. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7780.T's ROE of +0.06%. Regarding short-term risk, 7817.T is less volatile compared to 7780.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 3593.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 3593.T has a market cap of 85.70B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 3593.T trades at $3,975.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 3593.T's P/E ratio is 58.62. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3593.T's ROE of +0.02%. Regarding short-term risk, 7817.T is more volatile compared to 3593.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7979.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7979.T has a market cap of 74.65B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7979.T trades at $2,100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7979.T's P/E ratio is 16.77. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7979.T's ROE of +0.11%. Regarding short-term risk, 7817.T is more volatile compared to 7979.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 5889.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 5889.T has a market cap of 56.26B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 5889.T trades at $2,332.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 5889.T's P/E ratio is 14.31. In terms of profitability, 7817.T's ROE is +0.07%, compared to 5889.T's ROE of +0.27%. Regarding short-term risk, 7817.T is more volatile compared to 5889.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7749.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7749.T has a market cap of 36.26B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7749.T trades at $2,480.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7749.T's P/E ratio is 11.98. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7749.T's ROE of +0.07%. Regarding short-term risk, 7817.T is more volatile compared to 7749.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 3154.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 3154.T has a market cap of 21.15B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 3154.T trades at $951.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 3154.T's P/E ratio is 20.49. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3154.T's ROE of +0.05%. Regarding short-term risk, 7817.T is more volatile compared to 3154.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7743.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7743.T has a market cap of 13.68B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7743.T trades at $452.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7743.T's P/E ratio is 7.34. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7743.T's ROE of +0.09%. Regarding short-term risk, 7817.T is more volatile compared to 7743.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7775.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7775.T has a market cap of 13.59B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7775.T trades at $473.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7775.T's P/E ratio is 12.82. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7775.T's ROE of +0.15%. Regarding short-term risk, 7817.T is more volatile compared to 7775.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7702.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7702.T has a market cap of 10.54B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7702.T trades at $430.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7702.T's P/E ratio is -296.55. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7702.T's ROE of +0.00%. Regarding short-term risk, 7817.T is more volatile compared to 7702.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 3604.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 3604.T has a market cap of 6.94B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 3604.T trades at $1,198.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 3604.T's P/E ratio is 15.04. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3604.T's ROE of +0.07%. Regarding short-term risk, 7817.T is more volatile compared to 3604.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 3446.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 3446.T has a market cap of 6.60B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 3446.T trades at $1,120.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 3446.T's P/E ratio is 34.60. In terms of profitability, 7817.T's ROE is +0.07%, compared to 3446.T's ROE of +0.08%. Regarding short-term risk, 7817.T is less volatile compared to 3446.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7980.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7980.T has a market cap of 5.43B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7980.T trades at $763.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7980.T's P/E ratio is 8.00. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7980.T's ROE of +0.08%. Regarding short-term risk, 7817.T is more volatile compared to 7980.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 9340.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 9340.T has a market cap of 5.37B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 9340.T trades at $550.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 9340.T's P/E ratio is 11.70. In terms of profitability, 7817.T's ROE is +0.07%, compared to 9340.T's ROE of +0.17%. Regarding short-term risk, 7817.T is less volatile compared to 9340.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 4556.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 4556.T has a market cap of 5.29B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 4556.T trades at $1,256.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 4556.T's P/E ratio is 8.60. In terms of profitability, 7817.T's ROE is +0.07%, compared to 4556.T's ROE of +0.09%. Regarding short-term risk, 7817.T is more volatile compared to 4556.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7782.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7782.T has a market cap of 4.42B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7782.T trades at $691.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7782.T's P/E ratio is 14.62. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7782.T's ROE of +0.12%. Regarding short-term risk, 7817.T is less volatile compared to 7782.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7813.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7813.T has a market cap of 2.58B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7813.T trades at $726.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7813.T's P/E ratio is 29.71. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7813.T's ROE of +0.03%. Regarding short-term risk, 7817.T is more volatile compared to 7813.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.
7817.T vs 7090.T Comparison
7817.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7817.T stands at 138.71B. In comparison, 7090.T has a market cap of 1.59B. Regarding current trading prices, 7817.T is priced at $2,474.00, while 7090.T trades at $1,070.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7817.T currently has a P/E ratio of 18.85, whereas 7090.T's P/E ratio is 15.82. In terms of profitability, 7817.T's ROE is +0.07%, compared to 7090.T's ROE of -0.20%. Regarding short-term risk, 7817.T is more volatile compared to 7090.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7817.T.